|
|
|
|
|
|
|
An Pediatr (Barc) 2009,Dec,01;71(6):510-3; (PMID: 19811957)
[...]Initial treatment consists of symptomatic relief of cholestatic symptoms with choleretic agents (urso-deoxycholic acid). Partial biliary derivation and ileal bypass are intermediate therapeutic options. In case of no response to these treatments, [...]
|
|
|
J Hepatol 2009,Dec,01;51(6):1084-5; author reply 1085-6; (PMID: 19864037)
|
|
|
Cancer Prev Res (Phila Pa) 2009,Dec,01;2(12):1023-30; (PMID: 19952360)
PURPOSE: Ursodeoxycholic acid (UDCA) was one of the earliest agents investigated as a drug for colorectal cancer[...]
|
|
|
Acta Paediatr 2009,Nov,01;98(11):1756-61; (PMID: 19664101)
[...]METHODS: Medical records of all infants admitted to two Italian level III NICUs from January 2005 to August 2007 were retrospectively reviewed. The role of ursodeoxycholic acid (UDCA) therapy was also investigated. RESULTS: Twenty-seven of 1289 enrolled infants developed cholestasis[...]
|
|
|
Hepatol Res 2009,Nov,01;39(11):1144-9; (PMID: 19619254)
[...] were induced by EE, and the effects of MT on acute intrahepatic cholestasis were explored and compared with ursodeoxycholic acid (UDCA) by serum biochemical determination and bile excretion experiments. Results: The serum biochemical and bile biochemical results indicated that [...]
|
|
|
J Paediatr Child Health 2009,Nov,01;45(11):681-3; (PMID: 19845837)
[...]gold standard of therapy of surgical diversion may ultimately be unnecessary. We describe ursodeoxycholic acid as a useful adjunct to treatment allowing more time for clinicians to evaluate the nature of the underlying disease process without hastily moving towards invasive surgery until clearly indicated.[...]
|
|
|
Zhonghua Gan Zang Bing Za Zhi 2009,Nov,01;17(11):861-6; (PMID: 19958649)
[...]rheumatoid arthritis (3.95%) and diabetes type II (2.54%). Of the 507 patients treated with ursodeoxycholic acid (UDCA), 345 patients got complete or partial clinical biochemical response. The common complications were [...]
|
|
|
Dig Dis Sci 2009,Oct,01;54(10):2231-41; (PMID: 19082720)
We retrospectively reviewed the role of ursodeoxycholic acid in infants having nonsurgical cholestasis attending the Hepatology Clinic, New Children Hospital, Cairo University, Egypt, from 1985 until 2005.[...]
|
|
|
Hepatol Res 2009,Oct,01;39(10):1032-8; (PMID: 19796042)
[...], but the initial Mayo score remained the best predictor of survival. In addition to the well-known effects on biological parameters, ursodeoxycholic acid (UDCA) treatment has been associated with a stabilization or improvement of portal hypertension[...]
|
|
|
Carcinogenesis 2009,Oct,01;30(10):1813-20; (PMID: 19696165)
[...]-expressing cell line was fewer and smaller, respectively, than those formed by AKR1C1- and AKR1C2-expressing cells. Inhibitors of AKR1C, genistein and ursodeoxycholic acid, decreased foci formation in AKR1C1- and AKR1C2-expressing NIH3T3 cells in a dose-dependent manner, implying the association of [...]
|
 1 2 3 4 5 6 7 8 
|
|
|
|
|
